Shih Chun Ho
Director/Board Member at TRADE-VAN INFORMATION SERVICES CO.
Profile
Shih Chun Ho is currently the Chairman at Asia We Co., Ltd.
He also holds the position of Independent Director at Collins Co., Ltd., Director at Trade-Van Information Services Co., Independent Director at Super Dragon Technology Co., Ltd., Independent Director at Center Laboratories, Inc., Director at Allied Biotech Corp., Director at Forcera Materials Co. Ltd., Director at Ever Supreme Bio Technology Co., Ltd., Director at Luo Lih-Fen Holding Co., Ltd., and Member-Supervisory Board at Taiwan Lu.
Ti Investment Co. Ltd.
and IBT II Venture Capital Co., Ltd.
In the past, Mr. Ho served as Chairman at National Taiwan University and Independent Director at TPG Biologics, Inc. Mr. Ho completed his graduate degree at Golden Gate University and National Taiwan University.
He also holds an undergraduate degree from Fu Jen Catholic University.
Shih Chun Ho active positions
| Companies | Position | Start |
|---|---|---|
| TRADE-VAN INFORMATION SERVICES CO. | Director/Board Member | 1996-07-25 |
| CENTER LABORATORIES, INC. | Director/Board Member | 2010-06-13 |
| COLLINS CO., LTD. | Director/Board Member | 2016-06-09 |
| ALLIED BIOTECH CORPORATION | Director/Board Member | 2016-04-30 |
| EVER SUPREME BIO TECHNOLOGY CO., LTD | Director/Board Member | 2018-06-25 |
| LUO LIH-FEN HOLDING CO., LTD. | Director/Board Member | 2017-11-29 |
| SUPER DRAGON TECHNOLOGY CO., LTD | Director/Board Member | 2019-06-17 |
| FORCERA MATERIALS CO., LTD. | Director/Board Member | 2023-01-31 |
IBT II Venture Capital Co., Ltd.
 IBT II Venture Capital Co., Ltd. Investment ManagersFinance IBT II Venture Capital Co. Ltd. invests in companies located in Taiwan, the US, China, South East Asia, and Europe. The fund targets companies operating in the fields of consumer electronics, communications, semiconductors, optoelectronics, networking, computers, biotechnology, pharmaceuticals, healthcare services, green energy and environmental services. It provides financing for expansion, early and later stage capital requirements. | Director/Board Member | - |
| ░░░░ ░░ ░░░░ ░░░░ | ░░░░░░░░ | - |
| ░░░░░░ ░░ ░░ ░░░░░░░░░░ ░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Former positions of Shih Chun Ho
| Companies | Position | End |
|---|---|---|
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░░ | ░░░░░░░░ | - |
| ░░░ ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | - |
Training of Shih Chun Ho
| Golden Gate University | Graduate Degree |
| National Taiwan University | Graduate Degree |
| Fu Jen Catholic University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 8 |
|---|---|
| COLLINS CO., LTD. | Distribution Services |
| TRADE-VAN INFORMATION SERVICES CO. | Technology Services |
| SUPER DRAGON TECHNOLOGY CO., LTD | Industrial Services |
| CENTER LABORATORIES, INC. | Health Technology |
| ALLIED BIOTECH CORPORATION | Consumer Non-Durables |
| FORCERA MATERIALS CO., LTD. | Electronic Technology |
| EVER SUPREME BIO TECHNOLOGY CO., LTD | Health Technology |
| LUO LIH-FEN HOLDING CO., LTD. | Consumer Non-Durables |
| Private companies | 4 |
|---|---|
Taiwan Lu Ti Investment Co. Ltd.
 Taiwan Lu Ti Investment Co. Ltd. Financial ConglomeratesFinance Taiwan Lu Ti Investment Co. Ltd. is an investment company based in Taipei, Taiwan. | Finance |
IBT II Venture Capital Co., Ltd.
IBT II Venture Capital Co., Ltd. Investment ManagersFinance IBT II Venture Capital Co. Ltd. invests in companies located in Taiwan, the US, China, South East Asia, and Europe. The fund targets companies operating in the fields of consumer electronics, communications, semiconductors, optoelectronics, networking, computers, biotechnology, pharmaceuticals, healthcare services, green energy and environmental services. It provides financing for expansion, early and later stage capital requirements. | Finance |
TPG Biologics, Inc.
 TPG Biologics, Inc. Pharmaceuticals: MajorHealth Technology TPG Biologics, Inc. engages in the development of biopharmaceutical products. It offers antibody and protein drug design, cell line generation, process development, monoclonal antibody cell line similar drug products, and biological production for feasibility tests and animal studies. The company was founded on December 31, 2003 and headquartered in Taipei, Taiwan. | Health Technology |
| Asia We Co., Ltd. |
- Stock Market
- Insiders
- Shih Chun Ho
